NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

Related Keywords

New York ,United States ,Adolfo Garcia Sastre ,Adolfo Garc ,Michael Schotsaert ,Viviana Simon ,Danielle Ellis ,Randy Albrecht ,Evan Bakel ,Florian Krammer ,Us Department Of Health ,National Institutes Of Health ,National Institute Of Allergy ,Interagency Group ,Pathogens Institute At Icahn Mount Sinai ,Pathogens Institute ,Icahn School Of Medicine At Mount Sinai ,Global Health ,Genomic Sciences ,Human Service ,Mount Sinai Health System ,Mount Sinai Pathogen Surveillance Program ,Medicine Genetics ,Molecular Cell Based Medicine ,Icahn School ,Mount Sinai ,National Institutes ,Viral Evolution ,National Institute ,Infectious Diseases ,Mount Sinai Professor ,Icahn Mount Sinai ,Early Detection ,New York City ,Emerging Pathogens ,Tisch Cancer Institutes ,Icahn Mount ,Mount Sinai Health ,Emerging Pathogens Institute ,Sars ,Ars Cov 2 ,Allergy ,Bioinformatics ,Fell ,Children ,Covid 19 ,Efficacy ,Revolution ,Astroenterology ,Enetics ,Enomic ,Heart ,Hospital ,Immunity ,Mmunology ,N Vitro ,N Vivo ,Medicine ,Icrobiology ,Micron ,Pathology ,Protein ,Public Health ,Eagents ,Research ,Spike Protein ,Structural Biology ,Students ,Surgery ,Vaccine ,Virology ,Virus ,